The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
A few facts for you according to the folks from The Anxiety and Depression Association of America and the National Institute of Mental Health: In 2020, an estimated 14.8 million U.S. adults aged 18 or ...
August 10, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for dantrolene sodium injectable 20 mg/vial for the management of malignant hyperthermia; ...
NEW YORK, December 10 – Forest Laboratories, Inc. (NYSE: FRX) announced today the results of a clinical study, which showed that Lexapro TM (escitalopram oxalate) is as effective and well tolerated as ...
Drugmaker Lupin Pharmaceuticals Inc. announced today that the company has received FDA approval to market a generic version of Forest Laboratories’ antidepressant Lexapro. Escitalopram Tablets ...
Mylan announced the launch of Escitalopram tablets USP, the first generic version of Forest Laboratories’ Lexapro (escitalopram oxalate). Lexapro is a selective serotonin reuptake inhibitor (SSRIs) ...
In a single-center, double-blind, noninferiority trial involving adults with unipolar depression, we randomly assigned patients to receive tDCS plus oral placebo, sham tDCS plus escitalopram, or sham ...
Mumbai : Pharma company Lupin today said it has received US regulatory approval for Escitalopram Oxalate tablets, used in the treatment of depressive disorders. The company has received tentative ...
Teva announced the launch of Escitalopram tablets USP, the generic version of Forest Laboratories‘ Lexapro (escitalopram oxalate). Lexapro is a selective serotonin reuptake inhibitor (SSRIs) used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback